|
|
| | 3-methylcytidine Basic information |
| Product Name: | 3-methylcytidine | | Synonyms: | Cytidine, 3-methyl-;inhibit,3-Methylcytidine,Inhibitor,3Methylcytidine,Nucleoside Antimetabolite/Analog,3 Methylcytidine;RNA-modified?nucleoside?m3C;3-Methylcytidine, 10 mM in DMSO | | CAS: | 2140-64-9 | | MF: | C10H15N3O5 | | MW: | 257.24 | | EINECS: | | | Product Categories: | | | Mol File: | 2140-64-9.mol |  |
| | 3-methylcytidine Chemical Properties |
| Boiling point | 471.9±55.0 °C(Predicted) | | density | 1.71±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | |DMSO : 83.33 mg/mL (323.94 mM; Need ultrasonic) | | pka | 13.35±0.70(Predicted) | | form | Solid | | color | White to Off-White | | Water Solubility | Water : 90 mg/mL (349.87 mM; Need ultrasonic) |
| | 3-methylcytidine Usage And Synthesis |
| Uses | 3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1]. | | Definition | ChEBI: 3-methylcytidine is a methylcytidine. | | References | [1] Hsu WY, et al. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese. PLoS One. 2013 Dec 19;8(12):e81701. DOI:10.1371/journal.pone.0081701 |
| | 3-methylcytidine Preparation Products And Raw materials |
|